
Pharmaceutical Excipients Market, Global, 2024–2030
Description
This Frost & Sullivan report analyzes the global pharmaceutical excipients market, with a focus on key regional markets, including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa (MEA). The report provides both qualitative and quantitative analyses of various segments, including oral dosage excipients, injectable excipients, topical excipients, inhalable excipients, and ophthalmic excipients. The oral dosage excipients segment is further divided into the oral solid excipients and oral liquid excipients. Population aging, combined with a rising prevalence of diseases, is driving demand for diverse drug dosage formulations across all therapeutic areas. The oral route of drug administration is the most preferred due to its cost-effectiveness and better patient compliance. However, the inhalable route is expected to account for the most significant growth during the forecast period. This study offers a thorough understanding of the market dynamics that will shape the industry over the forecast period. It analyzes the factors driving and restraining market growth and identifies opportunities that arise from the changes in this space for market players and stakeholders to leverage. The base year for this report is 2024, while the forecast period extends from 2025 to 2030.
Table of Contents
- Scope of Analysis
- Scope and Segmentation
- Definitions
- Why is it Increasingly Difficult to Grow?
- The Strategic Imperative 8TM
- The Impact of the Top 3 Strategic Imperatives on the Pharmaceutical Excipients Industry
- Value Chain
- Competitive Environment
- Key Competitors
- Competitive Benchmarking-Oral Solid Dosages
- Competitive Benchmarking-Oral Liquid Dosages
- Competitive Benchmarking-Injectable
- Competitive Benchmarking-Topical
- Competitive Benchmarking-Inhalable
- Competitive Benchmarking-Ophthalmic
- Market Activities-Launches, M&As, Partnerships, and Expansions, 2022-2024
- Growth Metrics
- Growth Drivers
- Growth Driver Analysis
- Growth Restraints
- Growth Restraint Analysis
- Forecast Considerations
- Revenue Forecast
- Revenue Forecast Analysis
- Revenue Forecast by Type
- Revenue Forecast Analysis by Type
- Revenue Forecast by Region
- Revenue Forecast Analysis by Region
- Pricing Trends and Forecast Analysis
- Revenue Share
- Growth Metrics
- Revenue Forecast
- Revenue Forecast Analysis
- Revenue Forecast by Type
- Revenue Forecast by Type-Oral Solids
- Revenue Forecast by Sub-type-Binders and Fillers
- Revenue Forecast by Sub-type-Coatings
- Revenue Forecast by Sub-type-Disintegrants
- Forecast Analysis by Type-Oral Solids
- Revenue Forecast by Type-Oral Liquids
- Forecast Analysis by Type-Oral Liquids
- Revenue Forecast by Region
- Forecast Analysis by Region
- Growth Metrics
- Revenue Forecast
- Revenue Forecast Analysis
- Revenue Forecast
- Forecast Analysis by Type-Injectables
- Revenue Forecast by Region
- Forecast Analysis by Region-Injectables
- Growth Metrics
- Revenue Forecast
- Revenue Forecast Analysis
- Revenue Forecast
- Forecast Analysis by Type-Topical
- Revenue Forecast by Region
- Forecast Analysis by Region-Topical
- Growth Metrics
- Revenue Forecast
- Revenue Forecast Analysis
- Revenue Forecast
- Forecast Analysis by Type-Inhalable
- Revenue Forecast by Region
- Forecast Analysis by Region-Inhalable
- Growth Metrics
- Revenue Forecast
- Revenue Forecast Analysis
- Revenue Forecast
- Forecast Analysis by Type-Ophthalmic
- Revenue Forecast by Region
- Forecast Analysis by Region-Ophthalmic
- Growth Opportunity 1: Independent Approval Pathway for the Development of Novel Excipients
- Growth Opportunity 2: Inhaled Biologics
- Growth Opportunity 3: Patient-centric Formulations
- Benefits and Impacts of Growth Opportunities
- Next Steps
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.